| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Levy Adam D. | Chief Financial Officer | C/O ACRIVON THERAPEUTICS, INC., 480 ARSENAL WAY, SUITE 100, WATERTOWN | /s/ Adam D. Levy | 05 Aug 2025 | 0002061876 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ACRV | Common Stock | Tax liability | $1,467 | -1,164 | -8.7% | $1.26 | 12,151 | 01 Aug 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. |